Skip to content
Nanjing Red Sun logo
Corporate Investor

Updated:

Nanjing Red Sun

Nanjing Red Sun traces its roots to 1958, beginning as a collective agricultural chemicals workshop before founder Yang Shouhai guided it through China's...

Overview

Nanjing Red Sun traces its roots to 1958, beginning as a collective agricultural chemicals workshop before founder Yang Shouhai guided it through China's enterprise reforms to a public listing on the Shenzhen Stock Exchange. The core business remains the scientific research, formulation, and distribution of green pesticides — a category that aligns with Beijing's push for lower-toxicity agricultural inputs. The Shouhai family, now represented by second-generation Chairman Yi Yang, retains control of the publicly traded entity. The firm's deployment model blends direct operational spending on production infrastructure with minority joint ventures. Tangible assets include the Nanjing Gaochun Production Base in the Gaochun Economic Development Zone and the Anhui Dangtu Production Base in Ma'anshan prefecture — both industrial-scale chemical synthesis and formulation campuses. In adjacent fields, a joint venture with CK Life Sciences, Nanjing Green Union, develops biological agricultural products. The firm also holds mixed-use real estate development projects in Nanjing, extending its balance sheet into property assets linked to the broader Red Sun group ecosystem. Chairman Yi Yang oversees a corporate entity whose scale is measured in operating revenue rather than disclosed AUM. Historical corporate filings show the firm generating several hundred million USD in annual sales at peak periods, driven by domestic Chinese farm demand and export channels. The relationship with Zeng Huansha and Redsun Properties (Hong Yang) — a separately listed entity — further connects the core agricultural chemicals business to real estate development, though the extent of cross-ownership and capital flows remains opaque. The firm maintains professional laboratories in Nanjing, signaling continued investment in formulation science rather than purely volume-driven manufacturing. Red Sun's architecture is distinct for blending a listed operating company with family-controlled influence across chemically adjacent and real estate holdings — a structure common among first- and second-generation Chinese industrial families but rare in Western family-office comparisons. The philanthropic arm, Red Sun Group Charitable Initiatives, formalizes community investment separately from the commercial balance sheet, though governance separation between corporate R&D spending and charitable foundations is not publicly detailed.

General information

Firm type

Corporate Investor

Year founded

1958

Location

Region

Asia

Country

China

City

Nanjing

Corporate office

Nanjing, Jiangsu, China

Principals

Yang Shouhai

Founder and long-time Chairman

Yi Yang

Chairman of Nanjing Red Sun Co., Ltd.

Sector focus

AgriTech & FoodTechChemicals & MaterialsReal Estate

Frequently asked questions

Who runs investment decisions at Nanjing Red Sun?

Strategic capital allocation sits with the board and executive leadership under Chairman Yi Yang, who succeeded founder Yang Shouhai. As a listed entity, material investments require Shenzhen Stock Exchange disclosure and board approval, though the Yang family's controlling stake grants significant discretion over organic expansion, joint ventures, and adjacent real asset deployment.

How does Nanjing Red Sun source proprietary deal flow?

The firm sources opportunities primarily through government relationships tied to agricultural modernization policy, production-base expansion into provincial development zones, and the founder's long-standing business network. Joint ventures with foreign partners — notably CK Life Sciences in biological agriculture — originate from industry conferences, government matchmaking, and personal reputation within China's agrochemical sector.

Does Nanjing Red Sun participate in fund commitments or only direct deals?

The firm overwhelmingly deploys capital directly into wholly owned production assets and joint-venture equity stakes, rather than through third-party fund commitments. There is no public evidence of LP positions in agrochemical venture or growth funds. The joint venture with CK Life Sciences represents the primary external partnership structure.

What investment stages does Nanjing Red Sun typically target?

Nanjing Red Sun does not target venture investment stages in the typical sense. It makes greenfield and brownfield capital expenditures in manufacturing capacity, laboratory capability, and real estate — essentially direct infrastructure and industrial operating investments. Joint ventures like Nanjing Green Union represent co-development partnerships rather than staged financings.

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Corporate Investor profiles